The use of hormonal contraception and breast cancer

Article History

Submited : September 25, 2018
Published : January 4, 2019

The prevalence of breast cancer continues to increase in the world, including in Indonesia. The main factor causing breast cancer is not yet known certainly. The research was conducted to determine the correlation between hormonal contraceptive use and the prevalence of breast cancer. The research design was case control. The sampling technique used purposive sampling. The number of samples was 85 cases and 85 controls. The case group was women with breast cancer at RSUP Dr. Sardjito Yogyakarta in 2017. The control group was a woman who checked herself in Obsgyn RSUP Dr. Sardjito in 2017 who was not breast cancer and other cancers. The data collected through secondary data was taken from medical records. The analysis was done using Chi-square test and logistic regression. There was a significant correlation between hormonal contraceptive use and breast cancer prevalence p-value = 0.004 OR = 2.378 (95% CI 1.2282-4.412). The use of hormonal contraception increased the risk of breast cancer prevalence by 2.378 times. Other risk factors were found at age 40 years old p-value = 0.002 OR = 2.641 (95% CI 1.416-4.925), age of menarche <12 years p-value = 0.004 OR = 2.868 (95% CI 1.366-6.021), obesity p-value = 0.002 OR = 2.875 (95% CI 1.434-5.765), and nullipara p-value = 0.005 OR = 4.000 (95% CI 1.402-11.410). The suggestion was that midwives and prospective acceptors/acceptors of family planning pay attention to the risk factors for hormonal contraceptive use on breast cancer prevalence and other risk factors that affected breast cancer.

  1. World Health Organization (WHO). Cancer [Internet]. 2013. Available from: http://www.depkes.go.id/article/print/201407070001/hilangkan-mitos-tentang-kanker.html diakses tanggal 20 Oktober 2017.
  2. Kementerian Kesehatan RI. Pusat Data dan Informasi. Jakarta: Kementerian Kesehatan RI. 2015.
  3. Utami, Sri. Aku Sembuh dari Kanker Payudara. Yogyakarta: Oryza. 2012.
  4. Suryaningsih EK, Sukaca BE. Kupas Tuntas Kanker Payudara. Yogyakarta: Paradigma Indonesia. [Internet]. 2009. Available from: http://digilib. unimus. ac. id/files /disk1 /119/jtptunimus-gdl-apriliahid-5911-2-babii.pdf diakses pada tanggal 8 November 2017.
  5. Dewi GAT, Lucia YH. Breast Cancer Risk Analysis by the Use of Hormonal Contraceptives and Age of Menarche.Jurnal Berkala Epidemiologi. 2015 Januari. Vol. 3, No. 1 : 12–23.
  6. Sandra, Y. Melatonin dan Kanker Payudara. Majalah Kesehatan Pharma Medika. Vol. 3, No.2: 286-291. [Internet]. 2011. Accessed at 14 November 2017.
  7. Kementerian Kesehatan RI. Data dan Informasi Kesehatan Republik Indonesia 2016. Jakarta: Kementerian Kesehatan RI. 2017.
  8. Kementerian Kesehatan Republik Indonesia. Profil Kesehatan Kabupaten/ Kota DIY tahun 2014. Jakarta: Kementerian Kesehatan RI. 2015.
  9. Baziad A. Kontrasepsi Hormonal. Jakarta : PT Bina Pustaka Sarwono Prawirohardjo. 2008.
  10. Yager JD, Nancy ED. Estrogen Carcinogenesis in Breast Cancer. The New England Journal of Medicine. 2006. Vol. 354, No. 3: 270–282.
  11. Mangan, Y. Solusi Sehat Mencegah dan Mengatas iKanker. Jakarta: PT Agromedia Pustaka. [Internet]. 2010. Available from: https://books.google. co.id/books?id Accessed at 14 November 2017.
  12. Soroush A, Farschian N, Komasi S, Izadi N, Amirfrard N, Shah mohammadi A. The Roles Of Oral Contraceptive Pills On Increased Risk Of Breast Cancer In Iranian Populations. J Cancer Prev. 2016 Dec;21(4):294-301
  13. Rasjidi I. Epidemiologi Kanker pada Wanita. Jakarta: Sagung Seto. 2010.
  14. Baziad A. Kontrasepsi Hormonal. Jakarta : PT Bina Pustaka Sarwono Prawirohardjo. 2008.
  15. Damayanti D. 2001. Faktor-faktor yang Berhubungan dengan Umur Menarche Mahasiswi Baru S1 Regular UI. Skripsi. Fakultas Kesehatan Masyarakat, Universitas Indonesia. Depok.
  16. Setiowati DAI, Eddy HT, Roostantia IS. Hubungan antara Pemakaian KB Hormonal dengan Kejadian Kanker Payudara di Poli Onkologi Satu Atap RSUD Dr. Soetomo, Februari–April 2015. Indonesian Journal of Cancer 2016 January – March. Vol. 10, No. 1.
  17. Kumar V, Abbas A, Aster J. Robbins basic pathology. Edisi ke-9. Philadelphia: Elsevier;2013
  18. Pamela J, Goodwin. Obesity and Breast Cancer Outcomes: How Much Evidence Is Needed to Change Practice? Mount Sinai Hospital and University of Toronto, Toronto, Ontario, Canada. Journal of Clinical Oncology. 2016 March 1, Vol 34, No 7: 646-648.
  19. Lincoln, J dan Wilensky. 2008. Kanker Payudara Diagnosis dan Solusinya. Jakarta: Prestasi Pustakaraya.
  20. Priyatin C, Elisa U, Sri S. Faktor Risiko yang Berpengaruh terhadap Kejadian Kanker Payudara di RSUP Dr. Kariadi Semarang.Jurnal Kebidanan. 2013 Oktober Vol. 2 No. 5 ISSN. 2089-7669.
  21. Nani D. Analisis Faktor-Faktor yang Berhubungan dengan Kejadian Kanker Payudara di Rumah Sakit Pertamina Cilacap. Jurnal Keperawatan Soedirman (The Soedirman Journal of Nursing). 2009 Juli. Vol 4, No.2 .
Anggarini, D., Rahmawati, A., & Margono, M. (2019). The use of hormonal contraception and breast cancer. Jurnal Kesehatan Ibu Dan Anak, 12(2), 85-92. https://doi.org/10.29238/kia.v12i2.139
Fulltext